Cargando…
Considerations in boosting COVID-19 vaccine immune responses
Autores principales: | Krause, Philip R, Fleming, Thomas R, Peto, Richard, Longini, Ira M, Figueroa, J Peter, Sterne, Jonathan A C, Cravioto, Alejandro, Rees, Helen, Higgins, Julian P T, Boutron, Isabelle, Pan, Hongchao, Gruber, Marion F, Arora, Narendra, Kazi, Fatema, Gaspar, Rogerio, Swaminathan, Soumya, Ryan, Michael J, Henao-Restrepo, Ana-Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437678/ https://www.ncbi.nlm.nih.gov/pubmed/34534516 http://dx.doi.org/10.1016/S0140-6736(21)02046-8 |
Ejemplares similares
-
COVID-19 vaccine trials should seek worthwhile efficacy
por: Krause, Philip, et al.
Publicado: (2020) -
Booster vaccines for COVID-19 vaccine breakthrough cases? – Authors' reply
por: Krause, Philip R, et al.
Publicado: (2022) -
Making more COVID-19 vaccines available to address global needs: Considerations and a framework for their evaluation
por: Krause, Philip R, et al.
Publicado: (2022) -
SARS-CoV-2 Variants and Vaccines
por: Krause, Philip R., et al.
Publicado: (2021) -
COVID-19 vaccine trials: The use of active controls and non-inferiority studies
por: Fleming, Thomas R, et al.
Publicado: (2021)